PharMEDium Healthcare Holdings
Investors Count
4Deal Terms
3Funding, Valuation & Revenue
4 Fundings
PharMEDium Healthcare Holdings's latest funding round was a Dead for on January 30, 2020.
PharMEDium Healthcare Holdings's valuation in October 2015 was $2,575M.
PharMEDium Healthcare Holdings's latest post-money valuation is from October 2015.
Sign up for a free demo to see PharMEDium Healthcare Holdings's valuations in January 2014, November 2007 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/30/2020 | Dead | Dead | 1 | |||
10/6/2015 | Acquired | ▲$2,575M | ||||
1/29/2014 | Acq - Fin - II | |||||
11/9/2007 | Acq - Fin |
Date | 1/30/2020 | 10/6/2015 | 1/29/2014 | 11/9/2007 |
|---|---|---|---|---|
Round | Dead | Acquired | Acq - Fin - II | Acq - Fin |
Amount | ||||
Investors | Dead | |||
Valuation | ▲$2,575M | |||
Revenue | ||||
Sources | 1 |
PharMEDium Healthcare Holdings Deal Terms
3 Deal Terms
PharMEDium Healthcare Holdings's deal structure is available for 3 funding rounds, including their Acquired from October 06, 2015.
Round | Acquired | Acq - Fin - II | Acq - Fin |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Acq - Fin - II | |||||||||||||||
Acq - Fin |
PharMEDium Healthcare Holdings Investors
4 Investors
PharMEDium Healthcare Holdings has 4 investors. Cencora invested in PharMEDium Healthcare Holdings's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/6/2015 | 10/6/2015 | 1 Acquired | Corporation | Pennsylvania | ||
Private Equity | New York | |||||
Venture Capital | Connecticut | |||||
Private Equity | Illinois |
First funding | 10/6/2015 | |||
|---|---|---|---|---|
Last Funding | 10/6/2015 | |||
Investor | ||||
Rounds | 1 Acquired | |||
Board Seats | ||||
Type | Corporation | Private Equity | Venture Capital | Private Equity |
Location | Pennsylvania | New York | Connecticut | Illinois |
Compare PharMEDium Healthcare Holdings to Competitors
IntegriChain provides pharmaceutical commercialization and market access services within the healthcare technology sector. The company offers a data-driven platform, consulting, and business process outsourcing to assist with drug access and net revenue for pharmaceutical manufacturers. IntegriChain's services address several stages of the pharmaceutical lifecycle, including launches, managing in-line products, and portfolio expansion. It was founded in 2007 and is based in Philadelphia, Pennsylvania.
RxStrategies is a provider of discounted prescription medicines.
SFJ Pharmaceuticals is a specialty pharma company focused on the clinical development and registration of pharmaceutical products. The company offers services that include clinical development and regulatory resources necessary for the approval of pharmaceutical products. SFJ Pharmaceuticals primarily serves the pharmaceutical industry, providing an alternative approach to partnering for product development and registration. It is based in Pleasanton, California.
Allucent provides drug development solutions within the pharmaceutical and biotechnology sectors. The company offers services such as clinical trial management, regulatory strategy consulting, and biostatistical programming, which assist small and mid-sized biotech companies in drug development. Allucent serves clients in the pharmaceutical and biotechnology industries, with expertise in therapeutic areas including oncology, neurology, and autoimmune disorders. Allucent was formerly known as CATO SMS. It was founded in 2014 and is based in Cary, North Carolina.
Naviget specializes in converting two-dimensional medical scans into three-dimensional visualizations within the healthcare industry. The company provides services including web-based viewing, artificial intelligence analytics, and experiences to improve patient understanding and support healthcare collaboration. Its solutions are utilized by hospitals, diagnostic centers, and healthcare professionals. The company was founded in 2018 and is based in Saratoga, California.
Pharmaca is a pharmacy chain that offers traditional pharmacy services alongside natural and complementary health solutions, including natural health and beauty products. On June 30, 2021, Pharmaca Integrative Pharmacy was acquired by Medly Pharmacy. The terms of the transaction were not disclosed.
Loading...